LINC02881

Across TCGA pan-cancer cohorts, LINC02881 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC02881 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC02881 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02881 expression acts as an unfavorable survival marker, although some lineages such as THCA and ESCA show a favorable association.

OV, THCA, and ESCA are the cancer types where LINC02881 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	All	0.599	0.752	<.001	102	view →
THCA	DFS	Quartile	II,III,IV	1.000	0.349	<.001	59	view →
ESCA	DFS	Median	III,IV	0.479	0.238	.005	47	view →
UVM	DFS	Tertile	III,IV	0.290	0.625	.009	36	view →
UCS	DFS	Median	III,IV	0.588	0.275	.012	30	view →
LUSC	DFS	Quartile	All	0.279	0.492	.004	24	view →
SKCM	OS	Tertile	II,III,IV	0.557	0.356	.007	19	view →
ACC	DFS	Tertile	All	0.833	0.465	.024	18	view →
BRCA	OS	Median	All	0.663	0.498	.007	17	view →
PAAD	DFS	Tertile	II,III,IV	0.458	0.241	.010	15	view →
KIRC	DFS	Median	II,III,IV	0.553	0.744	.008	10	view →
LGG	OS	Tertile	All	0.402	0.540	.018	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC02881–OV (OS)

Open the OV breakdown →